Low birth weight is associated with poorer health outcomes—including CVD—later in life, according to a study out of West Virginia University.

An updated meta-analysis centered around the role marine omega-3 supplementation in CVD prevention suggests there may be a use for fish oil in cardiovascular medicine after all.

The FDA approved canagliflozin Sept. 30 to reduce the risk of end-stage kidney disease, worsening kidney function, CV death and hospitalization for heart failure in adults with type 2 diabetes and diabetic nephropathy.

A panel of 14 international scientists published a nutritional guideline in the Annals of Internal Medicine this month suggesting adults continue consuming both red meat and processed meats, basing the recommendation on a mega-review that found few adverse health effects with either product.

The higher the dosage of cholesterol-lowering statins, the greater a patient’s risk of developing osteoporosis, according to work published in the Annals of Rheumatic Diseases.

Torrent Pharmaceuticals Limited is the latest drug company to issue a recall of losartan potassium, a popular blood pressure drug that’s been under scrutiny for more than a year for containing probable human carcinogens.

Research presented at the American Heart Association’s Hypertension 2019 Scientific Sessions this month suggests having high blood pressure speeds up cognitive decline in middle-aged and older adults—but treating the condition can reverse that possibility.

Research out of UT Southwestern Medical Center in Dallas suggests at-home blood pressure monitoring is a more accurate approach to CV risk prediction in black patients.